308 related articles for article (PubMed ID: 21703291)
21. [Screening the differential expression of adriamycin-resistance related genes of breast cancer by cDNA microarray].
Peng H; Yang HW; Song LW; Zhou Z
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1745-8. PubMed ID: 19862977
[TBL] [Abstract][Full Text] [Related]
22. Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells.
Chekhun VF; Kulik GI; Yurchenko OV; Tryndyak VP; Todor IN; Luniv LS; Tregubova NA; Pryzimirska TV; Montgomery B; Rusetskaya NV; Pogribny IP
Cancer Lett; 2006 Jan; 231(1):87-93. PubMed ID: 16356834
[TBL] [Abstract][Full Text] [Related]
23. [Construction of glucosylceramide synthase-specific siRNA expression vector and its efficiency in reversal of drug resistance in breast carcinoma cells].
Sun YL; Zhou GY; Li KN; Li WT; Song XR; Gao P
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):518-21. PubMed ID: 15949329
[TBL] [Abstract][Full Text] [Related]
24. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Oncogene; 1997 Jan; 14(4):499-506. PubMed ID: 9053847
[TBL] [Abstract][Full Text] [Related]
25. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine.
Stipanuk MH
Annu Rev Nutr; 2004; 24():539-77. PubMed ID: 15189131
[TBL] [Abstract][Full Text] [Related]
26. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
27. Lessons Learned from Inherited Metabolic Disorders of Sulfur-Containing Amino Acids Metabolism.
Kožich V; Stabler S
J Nutr; 2020 Oct; 150(Suppl 1):2506S-2517S. PubMed ID: 33000152
[TBL] [Abstract][Full Text] [Related]
28. The presence of a transsulfuration pathway in the lens: a new oxidative stress defense system.
Persa C; Pierce A; Ma Z; Kabil O; Lou MF
Exp Eye Res; 2004 Dec; 79(6):875-86. PubMed ID: 15642325
[TBL] [Abstract][Full Text] [Related]
29. Molecular profile and cell cycle in MCF-7 and MCF-7/Dox cells exposed to conventional and liposomal forms of doxorubicin.
Rusetskaya NV; Lukyanova NY; Chekhun VF
Exp Oncol; 2009 Sep; 31(3):140-3. PubMed ID: 19783968
[TBL] [Abstract][Full Text] [Related]
30. Plasma homocysteine level and hepatic sulfur amino acid metabolism in mice fed a high-fat diet.
Yun KU; Ryu CS; Oh JM; Kim CH; Lee KS; Lee CH; Lee HS; Kim BH; Kim SK
Eur J Nutr; 2013 Feb; 52(1):127-34. PubMed ID: 22209966
[TBL] [Abstract][Full Text] [Related]
31. Effects of geranyl-phloroacetophenone on the induction of apoptosis and chemosensitization of adriamycin-resistant MCF-7 human breast cancer cells.
Cho MY; Park SY; Park S; Lee YR; Kwak MK; Kim JA
Arch Pharm Res; 2012 May; 35(5):911-9. PubMed ID: 22644859
[TBL] [Abstract][Full Text] [Related]
32. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.
Narang VS; Pauletti GM; Gout PW; Buckley DJ; Buckley AR
Chemotherapy; 2007; 53(3):210-7. PubMed ID: 17356269
[TBL] [Abstract][Full Text] [Related]
33. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
34. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Xu D; Lu Q; Hu X
Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
[TBL] [Abstract][Full Text] [Related]
36. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin.
Liebmann J; Fisher J; Lipschultz C; Kuno R; Kaufman DC
Cancer Res; 1995 Oct; 55(19):4465-70. PubMed ID: 7671261
[TBL] [Abstract][Full Text] [Related]
37. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines.
Azab SS; El-Demerdash E; Abdel-Naim AB; Youssef E; El-Sharkawy N; Osman AM
Biochem Pharmacol; 2005 Sep; 70(5):725-32. PubMed ID: 16005435
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
40. Expression of mRNA coding for TGF-beta and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin.
Chorna I; Fedorenko O; Datsyuk L; Stoika R
Exp Oncol; 2005 Jun; 27(2):156-8. PubMed ID: 15995636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
